Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Zenhäusern

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Praxis|March 28, 2013
[Indolent lymphomas: classification, clinical presentation and treatment]]Reinhard Zenhäusern
Clinical Genitourinary Cancer|September 30, 2017
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment RegistryFrank Stenner, Sacha I Rothschild, Daniel Betticher, et al.
Leukemia & Lymphoma|March 12, 2010
Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02)Nicolas Leupin, Jan C Schuller, Max Solenthaler, et al.
Cancer Chemotherapy and Pharmacology|August 25, 2019
Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN studySacha I Rothschild, Daniel Betticher, Reinhard Zenhäusern, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Praxis|March 28, 2013
[Indolent lymphomas: classification, clinical presentation and treatment]]Reinhard Zenhäusern
Clinical Genitourinary Cancer|September 30, 2017
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment RegistryFrank Stenner, Sacha I Rothschild, Daniel Betticher, et al.
Leukemia & Lymphoma|March 12, 2010
Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02)Nicolas Leupin, Jan C Schuller, Max Solenthaler, et al.
Cancer Chemotherapy and Pharmacology|August 25, 2019
Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN studySacha I Rothschild, Daniel Betticher, Reinhard Zenhäusern, et al.
Pageof 1